Armata Pharmaceuticals Stock Price on November 21, 2024
| ARMP Stock | USD 2.30 0.05 2.13% |
Below is the normalized historical share price chart for Armata Pharmaceuticals extending back to May 20, 1994. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Armata Pharmaceuticals stands at 2.30, as last reported on the 29th of November, with the highest price reaching 2.40 and the lowest price hitting 2.30 during the day.
If you're considering investing in Armata Stock, it is important to understand the factors that can impact its price. Currently, Armata Pharmaceuticals is risky. Armata Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0081, which signifies that the company had a 0.0081% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Armata Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Armata Pharmaceuticals' Downside Deviation of 4.2, risk adjusted performance of 0.0146, and Mean Deviation of 3.08 to double-check if the risk estimate we provide is consistent with the expected return of 0.0381%.
At this time, Armata Pharmaceuticals' Common Stock Shares Outstanding is relatively stable compared to the past year. As of 11/29/2024, Liabilities And Stockholders Equity is likely to grow to about 103.3 M, while Common Stock Total Equity is likely to drop slightly above 308.7 K. . As of 11/29/2024, Price To Sales Ratio is likely to drop to 24.52. In addition to that, Price Earnings Ratio is likely to drop to -1.78. Armata Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 9th of March 2011 | 200 Day MA 2.7588 | 50 Day MA 2.332 | Beta 0.805 |
Armata |
Sharpe Ratio = 0.0081
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ARMP |
Estimated Market Risk
| 4.69 actual daily | 41 59% of assets are more volatile |
Expected Return
| 0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Armata Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Armata Pharmaceuticals by adding Armata Pharmaceuticals to a well-diversified portfolio.
Price Book 4.0597 | Enterprise Value Ebitda (3.47) | Price Sales 22.3773 | Shares Float 11 M | Wall Street Target Price 7 |
Armata Pharmaceuticals Main Headline on 21st of November 2024
Armata Pharmaceuticals, Inc. Reports Earnings Results for th... by news.google.com
Armata Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 Marketscreener.com
Armata Pharmaceuticals Valuation on November 21, 2024
It is possible to determine the worth of Armata Pharmaceuticals on a given historical date. On November 21, 2024 Armata was worth 2.19 at the beginning of the trading date compared to the closed value of 2.1. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Armata Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Armata Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Armata Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Armata Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 1.99 | 2.16 | 1.99 | 2.09 | 18,394 | |
11/21/2024 | 2.19 | 2.19 | 2.10 | 2.10 | 8,544 |
| 2.20 | 2.26 | 2.15 | 2.25 | 5,165 |
| Backtest Armata Pharmaceuticals | | | Armata Pharmaceuticals History | | | Armata Pharmaceuticals Valuation | Previous | Next |
Armata Pharmaceuticals Trading Date Momentum on November 21, 2024
| On November 22 2024 Armata Pharmaceuticals was traded for 2.25 at the closing time. The top price for the day was 2.26 and the lowest listed price was 2.15 . The trading volume for the day was 5.2 K. The trading history from November 22, 2024 was a factor to the next trading day price gain. The overall trading delta against the next closing price was 7.14% . The overall trading delta against the current closing price is 11.90% . |
Armata Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Armata Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Armata Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Armata financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Armata Pharmaceuticals Stock history
Armata Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Armata is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Armata Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Armata Pharmaceuticals stock prices may prove useful in developing a viable investing in Armata Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 36.1 M | 37.9 M | |
| Net Loss | -33.2 M | -34.9 M |
Armata Pharmaceuticals Stock Technical Analysis
Armata Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Armata Pharmaceuticals Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Armata Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NYSE MKT Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Armata Pharmaceuticals November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Armata Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Armata Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Armata Pharmaceuticals stock market strength indicators, traders can identify Armata Pharmaceuticals entry and exit signals to maximize returns
Armata Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Armata Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Armata Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Armata to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0146 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.67) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.0928 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Armata Stock Analysis
When running Armata Pharmaceuticals' price analysis, check to measure Armata Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Armata Pharmaceuticals is operating at the current time. Most of Armata Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Armata Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Armata Pharmaceuticals' price. Additionally, you may evaluate how the addition of Armata Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.